Back to 2016 Annual Meeting Posters
Reduced Length of Hospital Stay for Mini-Invasive Aortic Valve Replacements after implementation of an Enhanced Recovery After Surgery Program
Pierre OSES, Sr., Cedrick Zaouter, Jocelyn Duchateau, Alexandre Ouattara, Louis Labrousse.
Bordeaux University Hospital, PESSAC, France.
OBJECTIVE: There is presently a warm enthusiasm for enhanced recovery after surgery (ERAS) program. A recent review indicates that length of hospital stay and postoperative complication could be reduced by 30 and 50%, respectively. However, most of the studies analyzed encompassed solely colorectal and orthopedic surgeries. Only one retrospective ERAS program has been described for mini-invasive cardiac surgery. Thus, in an effort to provide more evidence to the literature we have investigated prospectively the feasibility and clinical effectiveness of a dedicated ERAS program for mini-invasive Aortic Valve Replacements (AVR).
METHODS: Data were collected prospectively from consecutive patients scheduled for an AVR via a ministernotomy during 2 time periods, before (PRE-AVRERAS group) and after application of a dedicated ERAS pathway specifically designed for this mini-invasive cardiac procedure (AVRERAS group). Operative data, postoperative morphine consumption, postoperative data of interest, postoperative infection rates, types and rate of complications, 30-day type and rates of readmission were collected
RESULTS: There were 22 patients in the PRE-AVRERAS group, and 14 in the AVRERAS group. The median length of hospital stay was 9 days in the PRE-AVRERAS group compared to 5 days the AVRERAS group (P < 0.05). The results of postoperative interest are described in table 1. An ERAS pathway envisioned for mini-invasive AVR seems feasible and associated with a shorter length of hospital stay.
CONCLUSIONS: Our study indicates that an ERAS pathway could be implemented effectively with interesting results when a mini-invasive AVR is planned.
PRE¬-AVRERAS (n=22) | AVRERAS (n=14) | P¬Value | |
Logistic Euroscore | 12.4±4.1 | 15.5±3.2 | 0.06 |
Cross clamp time min. | 68±15.5 | 41±8.2 | 0.002 |
Sutureless valve implantation n(%) | 0 | 14(100) | <0.001 |
Postoperative morphine consumption | 8±10 | 3±3 | 0.079 |
Mobilization on a chair on the day of the surgery; n(%) | 0(0) | 11(79) | < 0.001 |
Transurethral catheter removal on the morning after surgery n(%) | 1(4.5) | 9(64) | <0.001 |
Overall infections during the hospitalization; n(%) | 8(36) | 1(7) | 0.06 |
Readmission for cardiac reasons; n(%) | 2(9) | 0(0) | 0.51 |
Extubation in operative room n(%) | 0 | 13(92.8) | <0.001 |
Back to 2016 Annual Meeting Posters